BE904226A - Derives 4-substitues d'androst-4-ene-3,17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication. - Google Patents
Derives 4-substitues d'androst-4-ene-3,17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication.Info
- Publication number
- BE904226A BE904226A BE0/216266A BE216266A BE904226A BE 904226 A BE904226 A BE 904226A BE 0/216266 A BE0/216266 A BE 0/216266A BE 216266 A BE216266 A BE 216266A BE 904226 A BE904226 A BE 904226A
- Authority
- BE
- Belgium
- Prior art keywords
- ene
- androst
- dione
- manufacture
- substituted derivatives
- Prior art date
Links
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 title abstract 2
- 239000003886 aromatase inhibitor Substances 0.000 title abstract 2
- BTTWKVFKBPAFDK-UHFFFAOYSA-N (9beta,10alpha)-Androst-4-ene-3,17-dione Natural products OC1CCC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 BTTWKVFKBPAFDK-UHFFFAOYSA-N 0.000 title 1
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 title 1
- 229940046844 aromatase inhibitors Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0027—Azides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
De nouveaux dérivés 4-substitués d'androst-4-éne-3,17-dione de formule I dans laquelle R est un groupe amino éventuellement substitué ou azido, l'un des restes R1 et R2 est l'hydrogène et l'autre est l'hydrogène ou un groupe alkyle, alcényle ou alcynyle, et (x) et (y) sont chacun indépendamment une liaison simple ou double. Applications : médicaments inhibiteurs de stéroide-aromatase utiles pour le traitement de tumeurs dépendantes des hormones.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858503940A GB8503940D0 (en) | 1985-02-15 | 1985-02-15 | 4-substituted androstendione derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE904226A true BE904226A (fr) | 1986-08-14 |
Family
ID=10574550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/216266A BE904226A (fr) | 1985-02-15 | 1986-02-14 | Derives 4-substitues d'androst-4-ene-3,17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4757061A (fr) |
| JP (1) | JPS61189295A (fr) |
| KR (1) | KR930005994B1 (fr) |
| AT (1) | AT396239B (fr) |
| AU (1) | AU577667B2 (fr) |
| BE (1) | BE904226A (fr) |
| CA (1) | CA1319362C (fr) |
| CH (1) | CH669199A5 (fr) |
| CZ (1) | CZ413691A3 (fr) |
| DE (1) | DE3604179A1 (fr) |
| DK (1) | DK167221B1 (fr) |
| ES (2) | ES8706165A1 (fr) |
| FI (1) | FI84272C (fr) |
| FR (1) | FR2577556B1 (fr) |
| GB (2) | GB8503940D0 (fr) |
| GR (1) | GR860430B (fr) |
| HK (1) | HK94090A (fr) |
| HU (1) | HU194909B (fr) |
| IE (1) | IE58864B1 (fr) |
| IT (1) | IT1190335B (fr) |
| MY (1) | MY102038A (fr) |
| NL (1) | NL8600383A (fr) |
| NZ (1) | NZ215163A (fr) |
| PT (1) | PT82030B (fr) |
| SE (2) | SE8600668L (fr) |
| SG (1) | SG80890G (fr) |
| SU (1) | SU1574178A3 (fr) |
| ZA (1) | ZA861118B (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8622330D0 (en) * | 1986-09-17 | 1986-10-22 | Erba Farmitalia | 4-substituted 6-alkylidenandrostene-3,17-dione derivatives |
| GB8624251D0 (en) * | 1986-10-09 | 1986-11-12 | Erba Farmitalia | "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives |
| DE3711772A1 (de) * | 1987-04-08 | 1988-10-27 | Schering Ag | 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung |
| GB8711579D0 (en) * | 1987-05-15 | 1987-06-17 | Erba Farmitalia | 4-amino-androstenedione derivatives |
| US5595985A (en) | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| DE69034148T2 (de) * | 1989-07-07 | 2005-06-30 | Endorecherche Inc., Ste-Foy | Kombinationstherapie zur Prophylaxe und/oder Behandlung von gutartiger prostatischer Hyperplasie |
| AU637247B2 (en) * | 1990-08-01 | 1993-05-20 | Merrell Dow Pharmaceuticals Inc. | 4-amino-delta4-steroids and their use as 5alpha-reductase inhibitors |
| AU642757B2 (en) * | 1990-08-01 | 1993-10-28 | Merrell Dow Pharmaceuticals Inc. | 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors |
| US5218110A (en) * | 1990-08-01 | 1993-06-08 | Merrell Dow Pharmaceuticals | 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors |
| US5143909A (en) * | 1991-03-19 | 1992-09-01 | Merrell Dow Pharmaceuticals Inc. | Aminosteroids in a method for inhibiting c17-20 lyase |
| US5318961A (en) * | 1990-08-01 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors |
| US5130424A (en) * | 1990-08-01 | 1992-07-14 | Merrell Dow Pharmaceuticals Inc. | 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors |
| US5120840A (en) * | 1990-08-01 | 1992-06-09 | Merrell Dow Pharmaceuticals Inc. | 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors |
| US5162337A (en) * | 1990-10-05 | 1992-11-10 | Merck & Co., Inc. | Animal growth promotion |
| US5189032A (en) * | 1991-03-19 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors |
| ATE154032T1 (de) * | 1991-03-28 | 1997-06-15 | Teikoku Hormone Mfg Co Ltd | Neue d-homo-17-oxa und d-homo-17-aza- androstanderivate |
| CH683151A5 (de) * | 1991-04-24 | 1994-01-31 | Ciba Geigy Ag | Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus. |
| GB9111260D0 (en) * | 1991-05-24 | 1991-07-17 | Erba Carlo Spa | Process for the preparation of 4-amino-unsaturated androstanedione derivatives |
| GB9217035D0 (en) * | 1992-08-11 | 1992-09-23 | Erba Carlo Spa | Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation |
| EP0663402B1 (fr) * | 1992-09-30 | 1999-04-21 | Teikoku Hormone Mfg. Co., Ltd. | Compose oxasteroide substitue en position 7 |
| WO1994019365A1 (fr) * | 1993-02-18 | 1994-09-01 | Farmitalia Carlo Erba Srl | Derives de 4-aminoandrostadienone fluores et procedes de preparation |
| US5486511A (en) * | 1993-05-25 | 1996-01-23 | Merrell Dow Pharmaceuticals Inc. | 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase |
| US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
| GB2284605A (en) * | 1993-12-09 | 1995-06-14 | Erba Carlo Spa | 6-or 7-substituted 4-aminoandrostadienone derivatives |
| ATE175419T1 (de) * | 1994-05-02 | 1999-01-15 | Merrell Pharma Inc | Verfahren zur herstellung von 4-amino-delta 4-3- ketosteroiden via 4-nitro-delta-4-3-ketosteroiden |
| US6365597B1 (en) | 1996-02-14 | 2002-04-02 | Aventis Pharmaceuticals Inc. | 4-aza steroids |
| US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
| US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
| US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
| US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
| US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US7435757B2 (en) * | 2004-07-02 | 2008-10-14 | Schering Ag | 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1042291A (en) * | 1961-11-08 | 1966-09-14 | Organon Labor Ltd | í¸-6ª‡-amino steroids and the preparation thereof |
| DE1203768B (de) * | 1962-02-01 | 1965-10-28 | Merck Ag E | Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Testosteronreiheund Saeureadditionssalzen derselben |
| DK120154B (da) * | 1968-02-29 | 1971-04-19 | Schering Ag | Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte. |
| DE1668690C3 (de) * | 1968-02-29 | 1978-09-14 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Androstan-Pregnan- und Cholestanreihe |
| US3780070A (en) * | 1972-09-21 | 1973-12-18 | Schering Corp | 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation |
| CA1154008A (fr) * | 1979-05-02 | 1983-09-20 | Thomas R. Blohm | INHIBITEURS DE STEROIDE 5.alpha.-REDUCTASE |
-
1985
- 1985-02-15 GB GB858503940A patent/GB8503940D0/en active Pending
-
1986
- 1986-02-10 US US06/828,637 patent/US4757061A/en not_active Expired - Fee Related
- 1986-02-10 DE DE19863604179 patent/DE3604179A1/de not_active Ceased
- 1986-02-10 HU HU86544A patent/HU194909B/hu not_active IP Right Cessation
- 1986-02-11 GB GB08603265A patent/GB2171100B/en not_active Expired
- 1986-02-11 AU AU53433/86A patent/AU577667B2/en not_active Ceased
- 1986-02-11 IT IT19361/86A patent/IT1190335B/it active
- 1986-02-11 CH CH549/86A patent/CH669199A5/de not_active IP Right Cessation
- 1986-02-13 JP JP61028062A patent/JPS61189295A/ja active Granted
- 1986-02-13 FI FI860672A patent/FI84272C/fi not_active IP Right Cessation
- 1986-02-13 GR GR860430A patent/GR860430B/el unknown
- 1986-02-14 DK DK071486A patent/DK167221B1/da not_active IP Right Cessation
- 1986-02-14 AT AT0038886A patent/AT396239B/de not_active IP Right Cessation
- 1986-02-14 NZ NZ215163A patent/NZ215163A/en unknown
- 1986-02-14 SU SU864021024A patent/SU1574178A3/ru active
- 1986-02-14 PT PT82030A patent/PT82030B/pt not_active IP Right Cessation
- 1986-02-14 CA CA000501861A patent/CA1319362C/fr not_active Expired - Fee Related
- 1986-02-14 ES ES552052A patent/ES8706165A1/es not_active Expired
- 1986-02-14 SE SE8600668D patent/SE8600668L/xx not_active Application Discontinuation
- 1986-02-14 NL NL8600383A patent/NL8600383A/nl not_active Application Discontinuation
- 1986-02-14 BE BE0/216266A patent/BE904226A/fr not_active IP Right Cessation
- 1986-02-14 FR FR8602051A patent/FR2577556B1/fr not_active Expired
- 1986-02-14 ZA ZA861118A patent/ZA861118B/xx unknown
- 1986-02-14 SE SE8600668A patent/SE468515B/sv unknown
- 1986-02-14 IE IE41386A patent/IE58864B1/en not_active IP Right Cessation
- 1986-02-15 KR KR1019860001070A patent/KR930005994B1/ko not_active Expired - Fee Related
- 1986-11-20 ES ES557215A patent/ES8708235A1/es not_active Expired
-
1988
- 1988-12-30 MY MYPI88001589A patent/MY102038A/en unknown
-
1990
- 1990-10-04 SG SG808/90A patent/SG80890G/en unknown
- 1990-11-15 HK HK940/90A patent/HK94090A/xx unknown
-
1991
- 1991-12-30 CZ CS914136A patent/CZ413691A3/cs unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE904226A (fr) | Derives 4-substitues d'androst-4-ene-3,17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication. | |
| ES8801509A1 (es) | Procedimiento para preparar esteroides sustituidos en posi- cion 10 | |
| TNSN87033A1 (fr) | TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES | |
| NZ331941A (en) | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis | |
| ATE33838T1 (de) | Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| IL73893A (en) | 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ES8504211A1 (es) | Procedimiento para la preparacion de derivados de oligoglucosido | |
| MY101614A (en) | Improvements in or relating to benzothiophene derivatives as antiasthmatic agents | |
| ATE44748T1 (de) | 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung. | |
| GR3001441T3 (en) | Pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity, its synthesis and use and a pharmaceutical composition containing it | |
| GB2256135B (en) | Transdermal administration of 4-substituted imidazoles | |
| FI890302A0 (fi) | Parannus androsta-1,4-dieeni-3,17-dionin 6-metyleenijohdannaisten synteesissä | |
| MY100512A (en) | New 6-or 7-methlenandrosta-1, 4-diene-3, 17-dione derivatives and process for their preparation. | |
| DK0533827T3 (da) | Oxazolderivater, deres fremstilling og farmaceutiske præparater deraf | |
| ATE47398T1 (de) | 10-beta-alkynyl-estrenderivate und verfahren zu ihrer herstellung. | |
| AP2000002001A0 (en) | Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the tnf relaease. | |
| ES8801278A1 (es) | Procedimiento para la obtencion de azabicicloheptanos sustituidos | |
| IL70082A (en) | Pharmaceutical compositions comprising 1-aroyl-5-oxo-2-pyrrolidinopropanoic acids and salts and esters thereof,certain such compounds and their preparation | |
| ES8302695A1 (es) | Procedimiento para la obtencion de nuevos compuestos de poliglicidilurazol n.substituidos. | |
| FR2562890B1 (fr) | Nouveaux composes nitrosourees. procede de preparation. composition a base de tels composes utiles notamment en chimiotherapie anticancereuse | |
| GB1333565A (en) | Therapeutic compositions | |
| MX9707006A (es) | Estratrienos de 17-difluorometileno. | |
| ES454700A1 (es) | Procedimiento para preparar composiciones herbicidas. | |
| YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.R.L. Effective date: 19960228 |